These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15638270)

  • 1. Cyclooxygenase-2 expression in canine appendicular osteosarcomas.
    Mullins MN; Lana SE; Dernell WS; Ogilvie GK; Withrow SJ; Ehrhart EJ
    J Vet Intern Med; 2004; 18(6):859-65. PubMed ID: 15638270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
    Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
    BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
    Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
    Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
    Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
    J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
    Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
    Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pathologic relevance of p53 index in canine osseous tumors.
    Loukopoulos P; Thornton JR; Robinson WF
    Vet Pathol; 2003 May; 40(3):237-48. PubMed ID: 12724563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose transporter 1 expression in canine osteosarcoma.
    Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
    Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
    Sottnik JL; Thamm DH
    Vet Comp Oncol; 2010 Jun; 8(2):96-102. PubMed ID: 20579322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
    Kleiter M; Malarkey DE; Ruslander DE; Thrall DE
    Vet Radiol Ultrasound; 2004; 45(3):255-60. PubMed ID: 15200266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
    Wolfesberger B; Walter I; Hoelzl C; Thalhammer JG; Egerbacher M
    Res Vet Sci; 2006 Jun; 80(3):308-16. PubMed ID: 16182328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.
    Mohammed SI; Khan KN; Sellers RS; Hayek MG; DeNicola DB; Wu L; Bonney PL; Knapp DW
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):479-83. PubMed ID: 15062852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.
    Selvarajah GT; Verheije MH; Kik M; Slob A; Rottier PJ; Mol JA; Kirpensteijn J
    Vet J; 2012 Aug; 193(2):412-9. PubMed ID: 22436430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.
    Gebhard C; Fuchs-Baumgartinger A; Razzazi-Fazeli E; Miller I; Walter I
    Can J Vet Res; 2016 Jan; 80(1):66-73. PubMed ID: 26733734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs.
    Sagartz JE; Bodley WL; Gamblin RM; Couto CG; Tierney LA; Capen CC
    Vet Pathol; 1996 Mar; 33(2):213-21. PubMed ID: 8801715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.
    Kruse MA; Holmes ES; Balko JA; Fernandez S; Brown DC; Goldschmidt MH
    Vet Pathol; 2013 Jul; 50(4):704-8. PubMed ID: 23269349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs.
    McEntee MF; Cates JM; Neilsen N
    Vet Pathol; 2002 Jul; 39(4):428-36. PubMed ID: 12126145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
    Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
    Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.
    Goupil RC; Bushey JJ; Peters-Kennedy J; Wakshlag JJ
    Vet Pathol; 2012 Sep; 49(5):802-10. PubMed ID: 22287649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating CXCR4 expression in canine appendicular osteosarcoma.
    Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
    J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.